IP Library › Granted Patent US 9,738,632
Granted Patent B2
US 9,738,632 · App. 15/367,936 · Granted Aug 22, 2017

Phenyl and benzodioxinyl substituted indazoles derivatives

Inventors: Markus Berger (Berlin, DE); Hartmut Rehwinkel (Berlin, DE); Jan Dahmen (Lund, SE); Anders Eriksson (Lund, SE); Thomas Hansson (Molndal, SE); Nafizal Hossain (Lund, SE); Per Tomas Klingstedt (Molndal, SE); Matti Lepisto (Molndal, SE); Stinabritt Nilsson (Molndal, SE); Martin Hemmerling (Molndal, SE); Karl Edman (Molndal, SE)
Assignees: AstraZeneca AB; Bayer Pharma Aktiengesellschaft
C07D409/14A61K31/416A61K31/4439A61K45/06C07D231/56C07D401/12C07D401/14C07D403/10C07D403/12C07D405/10C07D405/12C07D405/14C07D407/14C07D409/12C07D413/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,738,632
App. No.
15/367,936
Granted
Aug 22, 2017
Kind
B2
Abstract

A compound of formula Ia: The present invention relates to novel indazolyl derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments.

Claims (3)

1. A method of treating a glucocorticoid receptor mediated disease state, inflammatory condition, a respiratory condition, asthma and/or COPD in a mammal, which comprises administering to a mammal in need of such treatment an effective amount of a compound which is:

or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 , for treating asthma and/or COPD in a mammal.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2017
From: DAHMEN, JAN; ERIKSSON, ANDERS; HANSSON, THOMAS; HOSSAIN, NAFIZAL; KLINGSTEDT, PER TOMAS; LEPISTO, MATTI; NILSSON, STINABRITT; HEMMERLING, MARTIN; EDMAN, KARL
To: ASTRAZENECA AB
Reel/Frame 041979/0790 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2017
From: BERGER, MARKUS; REHWINKEL, HARTMUT
To: BAYER SCHERING PHARMA AG
Reel/Frame 041980/0198 →
CHANGE OF NAME Recorded Apr 12, 2017
From: BAYER SCHERING PHARMA AG
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 042233/0610 →
Continuity (7)
Continuation 14547809 · Nov 19, 2014
Continuation 13490204 · Jun 6, 2012
Continuation 12468561 · May 19, 2009
Provisional Application 61144776 · Jan 15, 2009
Provisional Application 61080312 · Jul 14, 2008
Provisional Application 61054616 · May 20, 2008
Related Publication 20170081315A1 · Mar 23, 2017